News / Marken expansion pushes UPS to forefront of pharma clinical trials sector

17/07/2019

Clinical trials specialist and UPS-subsidiary Marken has engaged in a wave of acquisitions to boost its presence in central Europe.

Its purchases of Austria’s Der Kurier, Hungary’s Heto and Italy’s HRTL appear to support UPS’s ambition to become a market leader in the clinical trials space.

Marken chief executive ...

To read this article you need to subscribe.

Help us to continue to invest in award-winning independent journalism. For an introductory offer of just £70 a year, or £10 per month, get access to all our daily news stories and opinion. If you are already a registered user, please login below with your current account's email and password to subscribe. If you are not registered and want to subscribe, please register below to subscribe.

Current subscriber

New subscriber